Skip to main content

5 Result(s)

within Intensive / Critical Care Medicine Remove this filter Internal Medicine Remove this filter E. Lange Remove this filter Article Remove this filter

and

  1. No Access

    Article

    Richter transformation in chronic lymphocytic leukemia (CLL)—a pooled analysis of German CLL Study Group (GCLLSG) front line treatment trials

    Richter transformation (RT) is defined as development of aggressive lymphoma in patients (pts) with CLL. The incidence rates of RT among pts with CLL range from 2 to 10%. The aim of this analysis is to report ...

    O. Al-Sawaf, S. Robrecht, J. Bahlo, A. M. Fink, P. Cramer, J. v Tresckow… in Leukemia (2021)

  2. No Access

    Article

    Residual abdominal lymphadenopathy after intensive frontline chemoimmunotherapy is associated with inferior outcome independently of minimal residual disease status in chronic lymphocytic leukemia

    M. Fürstenau, J. Bahlo, A. M. Fink, E. Lange, P. Dreger, M. Dreyling, G. Hess… in Leukemia (2020)

  3. Article

    Open Access

    Randomized phase-II trial evaluating induction therapy with idarubicin and etoposide plus sequential or concurrent azacitidine and maintenance therapy with azacitidine

    The aim of this randomized phase-II study was to evaluate the effect of substituting cytarabine by azacitidine in intensive induction therapy of patients with acute myeloid leukemia (AML). Patients were random...

    R. F. Schlenk, D. Weber, W. Herr, G. Wulf, H. R. Salih, H. G. Derigs… in Leukemia (2019)

    Download PDF (561 KB) View Article

  4. No Access

    Article

    Impact of gender on outcome after chemoimmunotherapy in patients with chronic lymphocytic leukemia: a meta-analysis by the German CLL study group

    O Al-Sawaf, S Robrecht, J Bahlo, A M Fink, P Cramer, J von Tresckow, C Maurer… in Leukemia (2017)

  5. No Access

    Article

    Randomized comparison of prophylactic and minimal residual disease-triggered imatinib after allogeneic stem cell transplantation for BCR–ABL1-positive acute lymphoblastic leukemia

    Minimal residual disease (MRD) after allogeneic stem cell transplantation (SCT) for Ph+ acute lymphoblastic leukemia (ALL) is predictive of relapse. Imatinib administration subsequent to SCT may prevent relaps...

    H Pfeifer, B Wassmann, W Bethge, J Dengler, M Bornhäuser, M Stadler, D Beelen… in Leukemia (2013)